Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2010
08/18/2010CN101804031A Preparation method of ribavirin-quaternized chitosan nanoparticles
08/18/2010CN101804030A Sodium dichlorophenolate micro-pill pharmaceutical preparation and preparation method thereof
08/18/2010CN101804029A Atorvastatin liposome and preparation method thereof, and medicine composition containing atorvastatin
08/18/2010CN101804028A Method for preparing traditional Chinese medicine liposome
08/18/2010CN101804027A Granisetron hydrochloride nasal spray and preparation method thereof
08/18/2010CN101804026A Preparation of interferon fat emulsion for injection
08/18/2010CN101804025A Aqueous solution injection for picoplatin
08/18/2010CN101804024A Gel taking 2beta, 3beta, 12,13-tetrahydroxy-oleanane-28-acid as active component
08/18/2010CN101804023A Gel taking 2alpha, 3beta, 12,13-tetrahydroxy-oleanane-28-carboxylate methyl ester as active component
08/18/2010CN101804022A Gel taking 2alpha, 3beta, 12,13-tetrahydroxy-oleanane-28-acid as active component
08/18/2010CN101804021A Preparation method of polyene-containing taxol nanoparticle mixed micelle preparation and freeze-drying agent
08/18/2010CN101623263B Cefminox sodium liposome preparation
08/18/2010CN101623260B Cefepime hydrochloride proliposome preparation
08/18/2010CN101601656B Edaravone liposome injection and new application thereof
08/18/2010CN101601654B Hydrochloric acid Fasudil liposome injection and new application thereof
08/18/2010CN101548957B Sub-micro emulsion frozen preparation of pantoprazole sodium prepared by using multiple emulsion method
08/18/2010CN101548956B Sub-micro emulsion frozen preparation of aztreonam
08/18/2010CN101536995B High imbibition dissoluble drug release external contraceptive membrane
08/18/2010CN101416944B Sodium ferulic acid nano micelle preparation and preparation method thereof
08/18/2010CN101381372B Pazufloxacin mesylate and preparation method of powder for injection
08/18/2010CN101348493B High-purity medicament and preparation thereof
08/18/2010CN101342145B Medicinal fine pellet core and preparation method
08/18/2010CN101322702B Piperacillin sodium and sulbactam sodium for injection and preparation of freeze-dried injection thereof
08/18/2010CN101322701B Amoxicillin sodium and sulbactam sodium for injection and preparation of freeze-dried injection thereof
08/18/2010CN101284011B Oleanolic acid orally disintegrating tablet and preparation method thereof
08/18/2010CN101279034B Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof
08/18/2010CN101278913B Novel polyethylene glycol-phospholipid entrapped prostaglandin E1 micelle preparation
08/18/2010CN101254178B Gliclazide controlled release tablets
08/18/2010CN101249173B Traditional Chinese medicine preparation for curing gout and method of preparing the same
08/18/2010CN101244135B Medicine label for treating rheumatism, hyperosteogeny
08/18/2010CN101240028B Conjugate constructed from normal pentadecyl and RGD peptide, and its synthesis and application in medicine
08/18/2010CN101234102B Peperphentonamine hydrochloride freeze-dried injection and preparation and application thereof
08/18/2010CN101199816B Medicament for anti-inflammation and analgesis
08/18/2010CN101199507B Application of furan diene and derivatives in preparing therapeautic cancer medicament
08/18/2010CN101181517B Chinese medicine medicinal granules for tonifying lung and relieving cough
08/18/2010CN101167705B Composition for preparing plant hollow hard capsule and preparation method of capsule
08/18/2010CN101164534B Application of curcumin in preparing tumor multi-medicine drug-resistant prevention agent
08/18/2010CN101152228B Genseng total sapnin micropore permeation pump, and its preparing method
08/18/2010CN101129713B Medicine for treating prostatosis and method for preparing same
08/18/2010CN101103994B Medicine for preventing and treating gout and hyperuricemia
08/18/2010CN101092363B Compound of lignanin aryl tetrahydronaphthalene, preparation method and application
08/18/2010CN101077403B Plaster for treating retention of food and dysmenorrhea
08/18/2010CN101040971B Chinese traditional medicine compound having functions of anti-acne, hole-complementarity and speckle-eliminating
08/18/2010CN101024029B Medicine for treating bony arthritis, rheumatism arthritis
08/18/2010CN101019911B Chinese medicine composition possessing antifatigue and immunoregulation functions
08/18/2010CN101007047B An antitumor medicine composition and its preparation method
08/17/2010US7779020 Small-footprint applicative query interpreter method, system and program product
08/17/2010US7777091 Hydrophilic dressing material in which a wound contact layer, having a sponge structure composed of multiple open cells and pores that make a tunnel from cell to cell, is laminated with a protective film
08/17/2010US7777012 Method of preparing a protein aggregate and a pharmaceutical preparation
08/17/2010US7776952 Block copolymer with a polydimethylsiloxane bound to its terminal end by a chlorine- or glycidyl ether group, or with a halocarbon, such as pentafluorobenzyl bromide or isocyanate; dispersion of a solvent and a supercritical fluid where the copolymer has an affinity for the supercritical fluid
08/17/2010US7776915 a lipoic acid, a carnitine, and a carnosine in a suitable vehicle for topical application for treating skin; useful in improving the appearance of aged skin characterized by wrinkles and loss of elasticity; preferred components include R-lipoic acid or R-dihydrolipoic acid, acetyl-1-carnitine,1-carnosin
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776846 Administering a synergistic mixture of a cortisone, hydrocortisone and/or prednisolone derivative; antiasthmatic agents; side effect reduction
08/17/2010US7776383 Ceramic nanomaterial; electrodes overcoated with multilayer ceramic film; sintering
08/17/2010US7776368 protective devices comprising flexible impervious elastomers having powders of plant extracts on the surfaces
08/17/2010US7776367 modifying surface of skin by giving skin smoother appearance through reduction of depth of wrinkles and fine lines and/or by providing skin with a re-plumping effect by applying a cosmetic composition comprising an extract of an exudate of the plant Daniellia oliveri
08/17/2010US7776360 (Polyalkoxy)sulfonate surface modifiers
08/17/2010US7776359 mixture of dextran polymer grafted with homo-oligomers of L-lactic acid, and dextran polymer grafted with homo-oligomers of D-lactic acid in an aqueous system,wherein homo-oligomers of L-lactic acid and homo-oligomers of D-lactic acid have 7-25 lactic acid monomers on average; biodegradable
08/17/2010US7776358 tablet core, which comprises at least 70% venlafaxine besylate and coating over tablet core which comprises an ammonio methacrylate copolymer component, wherein coating is in an amount within the range of 3% to 25% of the weight oftablet core
08/17/2010US7776357 For inserting one or several chemical or biological species into phospholipid containers that are controlled within a microfluidic network, wherein individual containers are tracked and manipulated by electric fields and wherein the contained species may be chemically processed
08/17/2010US7776356 Membrane devices with elastic energy barriers
08/17/2010US7776355 Skin drug delivery system with pads and liquids with insoluble drugs
08/17/2010US7776349 Organo-gel formulations for therapeutic applications
08/17/2010US7776345 Gastric retention controlled drug delivery system
08/17/2010US7776342 Preparations that potentiate immunogenicity in low immunogenic antigens
08/17/2010US7776339 dermatocosmetic composition for treating or reducing skin wrinkles; comprising a proteinaceous extract of Rhizomucor miehei free of acid-protease activity; wrinkle resistance; aging resistance; collagen regeneration; tissue engineering
08/17/2010US7776338 useful for enhancing immune response to antigens; lack ganglioside binding activity; applicable to mucosal immunization in humans
08/17/2010US7776332 infant formula which includes casein protein and whey protein; malnutrition; free of arginine and histidine; has an amino acid profile which is close to that of human milk
08/17/2010US7776319 Methods and compositions for treatment of ion imbalances
08/17/2010US7776315 Pharmaceutical compositions based on anticholinergics and additional active ingredients
08/17/2010US7776314 Abuse-proofed dosage system
08/17/2010US7776240 Injectable hydrogel microspheres from aqueous two-phase system
08/17/2010US7776031 Method and apparatus to control drug therapy dosages in an implantable pump
08/17/2010US7776029 Microminiature infusion pump
08/17/2010US7776024 Method of actuating implanted medical device
08/17/2010CA2601304C Controlled release formulations of octreotide
08/17/2010CA2530216C The use of an edible acid or the potassium or sodium salt thereof in the treatment of allergy
08/17/2010CA2529393C Sustained release formulation for venlafaxine hydrochloride
08/17/2010CA2473203C Orodispersible pharmaceutical composition comprising ivabradine
08/17/2010CA2473201C Orodispersible pharmaceutical composition comprising agomelatine
08/17/2010CA2418967C Improved hard sugar coating method
08/17/2010CA2412173C Nucleated molded article, method of producing the same, and device for producing the same
08/17/2010CA2389036C Antisense modulation of integrin-linked kinase expression
08/17/2010CA2383814C Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
08/17/2010CA2352563C Method to produce inactivated w/o emulsion adjuvanted vaccines
08/17/2010CA2318008C Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound
08/17/2010CA2302522C Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
08/17/2010CA2200695C Cationic transport reagents
08/17/2010CA2169260C Gene therapy for solid tumors, papillomas and warts
08/12/2010WO2010091287A1 Process for purifying guar
08/12/2010WO2010091274A1 A cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
08/12/2010WO2010091206A1 Compositions and uses to govern cancer cell growth
08/12/2010WO2010091197A2 Tablets for combination therapy
08/12/2010WO2010090876A2 Satiation peptide administration
08/12/2010WO2010090850A1 Methods for treating or preventing radiocontrast agent induced kidney injury
08/12/2010WO2010090765A2 Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products
08/12/2010WO2010090677A1 Clostridial toxin pharmaceutical compositions
08/12/2010WO2010090654A1 Methods of reducing the proliferation and viability of microbial agents
08/12/2010WO2010090614A1 Pharmaceutical formulation comprising risedronate, calcium carbonate and vitamin d3 combined in a single dosage form
08/12/2010WO2010090612A1 Stable, taste and odor masked pharmaceutical compositions comprising acetylcystein and vitamin c
1 ... 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 ... 2991